日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TRIM13 in situ engineering boosts anti-inflammatory capacity of CAR-Ms for liver fibrosis therapy

TRIM13原位工程改造增强CAR-Ms的抗炎能力,用于肝纤维化治疗

Gao, Jinxin; Yang, Zhenmei; Song, Yudong; Shao, Lijuan; Dong, Xianghui; Li, Caiping; Bo, Longyu; Zhao, Xiaotian; Han, Maosen; Tang, Chunwei; Fu, Zhipeng; Dai, Kuan; Li, Yintao; Li, Na; Li, Tao; Chen, Chen; Jiang, Xinyi; Zhao, Kun

Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma

基于SIGLEC9的合成嵌合开关受体增强CAR巨噬细胞对胶质母细胞瘤的疗效

Fu, Zhipeng; Zhao, Xiaotian; Zhang, Qikang; Han, Maosen; Zhang, Jing; Yang, Zhenmei; Wang, Yan; Yao, Zichao; Liu, Ying; Tang, Chunwei; Xi, Kaiyan; Liu, Zhanyan; Zhang, Yi; Zhao, Kun; Li, Na; Zhang, Yulin; Song, Yudong; Jiang, Xinyi; Chen, Chen

Synthetic efferocytic receptor microglia enhances anti-inflammatory clearance of amyloid-β for AD treatment in mice.

合成吞噬受体小胶质细胞增强抗炎清除淀粉样蛋白β的功效,用于治疗小鼠的阿尔茨海默病

Shao Lijuan, Zhang Yi, Yang Zhenmei, Shi Chongdeng, Yue Xiao, Li Caiping, Liu Ying, Fu Zhipeng, Tang Chunwei, Zhao Xiaotian, Han Maosen, Zhang Jing, Sun Weiyi, Yao Zichao, Xi Kaiyan, Fang Zezheng, Wang Zixu, Feng Fan, Ma Chunhong, Zhao Kun, Zhang Yulin, Ni Shilei, Jiang Xinyi, Chen Chen